Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The START Study: RBT-1 for Preconditioning in Cardiac Surgery
NCT04564833Phase 2Completed
- Sponsor
- Renibus Therapeutics
- Start
- Aug 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of stannic protoporfin + iron sucrose in acute kidney injury (AKI), sponsored by Renibus Therapeutics. Primary endpoint: Composite of Preconditioning Response Biomarkers. Started Aug 2021; status: completed.
02
Drugs
stannic protoporfin + iron sucrose
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04564833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04564833.